These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6140700)

  • 1. A comparison of some psychological and physiological effects exerted by zetidoline (DL308) and by oxazepam.
    Herbert M; Standen PJ; Short AH; Birmingham AT
    Psychopharmacology (Berl); 1983; 81(4):335-9. PubMed ID: 6140700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central effects of beta-adrenoceptor antagonists. I--Performance and subjective assessments of mood.
    Currie D; Lewis RV; McDevitt DG; Nicholson AN; Wright NA
    Br J Clin Pharmacol; 1988 Aug; 26(2):121-8. PubMed ID: 2905148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparison of the effects of DL-308, a potential new neuroleptic agent, and thioridazine on some psychological and physiological functions in healthy volunteers.
    Szabadi E; Bradshaw CM; Gaszner P
    Psychopharmacology (Berl); 1980; 68(2):125-34. PubMed ID: 6107945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between doses of oxazepam and their effects on performance of a standardised test battery.
    Kerr JS; Hindmarch I; Sherwood N
    Eur J Clin Pharmacol; 1992; 42(5):507-10. PubMed ID: 1606996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies--Part I.
    Saletu B; Grünberger J; Linzmayer L; Dubini A
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):489-95. PubMed ID: 6139346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the effects of oxazepam and diazepam in actual highway driving and neurocognitive test performance: a validation study.
    Jongen S; Vuurman EFPM; Ramaekers JG; Vermeeren A
    Psychopharmacology (Berl); 2018 Apr; 235(4):1283-1294. PubMed ID: 29500585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative abuse liability of diazepam and oxazepam: behavioral and subjective dose effects.
    Griffiths RR; McLeod DR; Bigelow GE; Liebson IA; Roache JD
    Psychopharmacology (Berl); 1984; 84(2):147-54. PubMed ID: 6438672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychophysiological measurements after oral atropine in man.
    Seppälä T; Visakorpi R
    Acta Pharmacol Toxicol (Copenh); 1983 Jan; 52(1):68-74. PubMed ID: 6837325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oxazepam on eye movements and performance in vigilance tasks with static and dynamic stimuli.
    van Leeuwen TH; Verbaten MN; Koelega HS; Camfferman G; van der Gugten J; Slangen JL
    Psychopharmacology (Berl); 1994 Feb; 114(1):109-18. PubMed ID: 7846192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lorazepam and oxazepam on perceptual and procedural memory functions.
    Martin J; Matthews A; Martin F; Kirkby KC; Alexander J; Daniels B
    Psychopharmacology (Berl); 2002 Nov; 164(3):262-7. PubMed ID: 12424549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The behavioral actions of diazepam and oxazepam are similar.
    Mewaldt SP; Ghoneim MM; Hinrichs JV
    Psychopharmacology (Berl); 1986; 88(2):165-71. PubMed ID: 3081928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An examination of differences in the time course of oxazepam's effects on implicit vs explicit memory.
    Buffett-Jerrott SE; Stewart SH; Bird S; Teehan MD
    J Psychopharmacol; 1998; 12(4):338-47. PubMed ID: 10065907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The psychomotor effects of paroxetine alone and in combination with haloperidol, amylobarbitone, oxazepam, or alcohol.
    Cooper SM; Jackson D; Loudon JM; McClelland GR; Raptopoulos P
    Acta Psychiatr Scand Suppl; 1989; 350():53-5. PubMed ID: 2530791
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacopsychological effects of oxazepam and kava-extract in a visual search paradigm assessed with event-related potentials.
    Heinze HJ; Münthe TF; Steitz J; Matzke M
    Pharmacopsychiatry; 1994 Nov; 27(6):224-30. PubMed ID: 7870743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of additional oxazepam in long-term users of oxazepam.
    Voshaar RC; Verkes RJ; van Luijtelaar GL; Edelbroek PM; Zitman FG
    J Clin Psychopharmacol; 2005 Feb; 25(1):42-50. PubMed ID: 15643099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study to evaluate the effect of ondansetron on psychomotor performance after repeated oral dosing in healthy subjects.
    Hall ST; Ceuppens PR
    Psychopharmacology (Berl); 1991; 104(1):86-90. PubMed ID: 1679243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepine-induced sedation and cortisol suppression. A placebo-controlled comparison of oxazepam and nitrazepam in healthy male volunteers.
    Christensen P; Lolk A; Gram LF; Kragh-Sørensen P
    Psychopharmacology (Berl); 1992; 106(4):511-6. PubMed ID: 1349754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroencephalographic and psychomotor effects of chlorpromazine and risperidone relative to placebo in normal healthy volunteers.
    Hughes AM; Lynch P; Rhodes J; Ervine CM; Yates RA
    Br J Clin Pharmacol; 1999 Sep; 48(3):323-30. PubMed ID: 10510142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihistamine activity and central effects of WAL 801 CL in man.
    Adamus WS; Oldigs-Kerber J; Lohmann HF
    Eur J Clin Pharmacol; 1987; 33(4):381-5. PubMed ID: 2894993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.
    Lile JA; Stoops WW; Wagner FP; Glaser PE; Rush CR
    Pharmacol Biochem Behav; 2005 Oct; 82(2):270-9. PubMed ID: 16182353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.